Company: CI
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001739940-25-000028
Chunk: 202

Company: Cigna Group
Filing Date: 2025-07-31
Form: 10-Q
Item: Part I, Item 8
Chunk 202
---
 ofDilutionDilutedBasicEffect ofDilutionDilutedShareholders' net income$1,532 $1,532 $1,548 $1,548 Shares:Weighted average266,181 266,181 281,133 281,133 Common stock equivalents1,973 1,973 2,919 2,919 Total shares266,181 1,973 268,154 281,133 2,919 284,052 Earnings per share$5.76 $(0.05)$5.71 $5.51 $(0.06)$5.45 

12

Six Months EndedJune 30, 2025June 30, 2024(Shares in thousands, dollars in millions, except per share amounts)BasicEffect ofDilutionDilutedBasicEffect ofDilutionDilutedShareholders' net income$2,855 $2,855 $1,271 $1,271 Shares:Weighted average268,511 268,511 283,799 283,799 Common stock equivalents2,029 2,029 3,085 3,085 Total shares268,511 2,029 270,540 283,799 3,085 286,884 Earnings per share$10.63 $(0.08)$10.55 $4.48 $(0.05)$4.43 

The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect was anti-dilutive:Three Months Ended June 30,Six Months Ended June 30,(In millions)2025202420252024Anti-dilutive options1.5 0.8 1.9 1.2 

The Company held approximately 137.4 million shares of common stock in treasury as of June 30, 2025, 128.7 million shares as of December 31, 2024 and 122.5 million shares as of June 30, 2024.

Note 7 – Debt

Short-Term and Long-Term Debt. During the six months ended June 30, 2025, the Company redeemed at par its $700 million 5.685% senior notes that were due March 2026 and repaid $900 million 3.250% senior notes that matured in April